Perrigo sets production records; Sanofi's Viehbacher pleased with Irish plant;

> Despite adding processes and procedures to improve quality, which slowed manufacturing throughput, Perrigo ($PRGO) CEO Joseph Papa said in a conference call that the drugmaker has "set production records over the past few months." Transcript

> "We are extremely happy with how the facility is performing," says Sanofi ($SNY) CEO Chris Viehbacher (photo) regarding the newly expanded former Genzyme plant in Waterford, Ireland. Story

> Indian bulk drugs maker Parabolic said it has received official accreditation from Japan's ministry of health to supply the antibiotic cephalosporin in that country. Story

> Use of plastic containers for drug products complicates choice of label material--components in inks, lacquers, top coats, adhesives, paper and film can leach through the container wall, contaminating medicine. Story

> Contract manufacturer CoreRx has added an Xcelodose precision powder micro-dosing system to its product development arsenal, citing client requirements for preclinical and early phase clinical GMP supply. Announcement

> Pharmetics/Jarvis Pharma and the Town of Fort Erie, Ontario, Canada, are paying consultancy Deloitte $100,000 to assess the viability and options of a manufacturing plant there. Story

> A $313 million investment by respiratory drugmaker Nephron Pharmaceuticals will open up 707 jobs in Lexington County, SC.  Story

> A group of public interest organizations from across the globe want the World Health Organization to disassociate from the International Medical Products Anti-Counterfeiting Taskforce and stop using the word "counterfeit" to refer to medical products of compromised quality, safety and efficacy. Story